Kiniksa Pharmaceuticals International (KNSA) Other Gross PP&E Adjustments (2021 - 2025)
Kiniksa Pharmaceuticals International (KNSA) has disclosed Other Gross PP&E Adjustments for 5 consecutive years, with -$6.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 16.43% year-over-year to -$6.0 million, compared with a TTM value of -$6.0 million through Dec 2025, down 16.43%, and an annual FY2025 reading of -$6.0 million, down 16.43% over the prior year.
- Other Gross PP&E Adjustments was -$6.0 million for Q4 2025 at Kiniksa Pharmaceuticals International, down from -$4.9 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $2.6 million in Q3 2021 and bottomed at -$15.0 million in Q3 2024.
- Average Other Gross PP&E Adjustments over 5 years is -$5.1 million, with a median of -$6.1 million recorded in 2025.
- The sharpest move saw Other Gross PP&E Adjustments crashed 186850.0% in 2022, then surged 90.97% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at $266000.0 in 2021, then crashed by 3354.51% to -$8.7 million in 2022, then increased by 19.54% to -$7.0 million in 2023, then rose by 26.23% to -$5.1 million in 2024, then dropped by 16.43% to -$6.0 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for KNSA at -$6.0 million in Q4 2025, -$4.9 million in Q3 2025, and -$7.0 million in Q2 2025.